Sekisui Chemical Co Ltd (4204):企業の財務・戦略的SWOT分析

◆英語タイトル:Sekisui Chemical Co Ltd (4204) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8011581
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月12日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:化学・材料
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sekisui Chemical Co Ltd (4204) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sekisui Chemical Co Ltd (Sekisui Chemical) is a chemical company that manufactures and markets plastic and other chemical products. The company offers semiconductor materials, LCD fine particles, photosensitive materials, optical film, industrial tapes and UV sealants to electronics market; polyolefin foam, interlayer films, molded resin products and industrial tapes to automobiles and transportation markets; functional resins, polyolefin foam, non-flammable polyurethane and fire-resistant materials to building and infrastructure markets; testing equipment, diagnostic pharmaceuticals, pharmaceuticals, drug-discovery support and sanitary materials to life science markets; and adhesives, tapes, polyvinyl alcohol resins and plastic containers to industrial markets. It provides PVC pipes and fittings, plastic valves, pipeline renewal materials, polyethylene pipes and fittings, reinforced plastic composite pipes and water storage tanks to piping and infrastructure markets; Building and insulation materials, care equipment, functional tatami and unit baths to building and living environment markets; and fiber-reinforced foamed urethane (FFU), plastic sheets, thermoplastic CFRP, soundproof materials, blow mold containers and agriculture and construction materials. The company also offers environmentally-friendly housing services in domestic and overseas markets. Sekisui Chemical is headquartered in Osaka, Japan.

Sekisui Chemical Co Ltd Key Recent Developments

Apr 15,2017: Sekisui Specialty Chemicals Announces Global Price Increase
Mar 29,2017: Sekisui Chemical: Commercialize film type dye sensitized solar cell by room temperature process
Feb 15,2017: Sekisui Specialty Chemicals Announces Global Price Increase
Dec 01,2016: Sekisui Specialty Chemicals Announces Asia Price Increase
Oct 01,2016: Sekisui Specialty Chemicals Announces Global Price Increase

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Sekisui Chemical Co Ltd – Key Facts 6
Sekisui Chemical Co Ltd – Key Employees 7
Sekisui Chemical Co Ltd – Key Employee Biographies 8
Sekisui Chemical Co Ltd – Major Products and Services 9
Sekisui Chemical Co Ltd – History 10
Sekisui Chemical Co Ltd – Company Statement 12
Sekisui Chemical Co Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 16
Company Overview 16
Sekisui Chemical Co Ltd – Business Description 16
Business Segment: Housing Company 16
Overview 16
Performance 16
Business Segment: HPP Company 16
Overview 16
Performance 17
Key Stats 17
Business Segment: UIEP Company 17
Overview 17
Performance 17
Sekisui Chemical Co Ltd – Corporate Strategy 18
Sekisui Chemical Co Ltd – SWOT Analysis 19
SWOT Analysis – Overview 19
Sekisui Chemical Co Ltd – Strengths 19
Sekisui Chemical Co Ltd – Weaknesses 20
Sekisui Chemical Co Ltd – Opportunities 21
Sekisui Chemical Co Ltd – Threats 22
Sekisui Chemical Co Ltd – Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Sekisui Chemical Co Ltd, Petrochemicals, Deals By Year, 2011 to YTD 2017 31
Sekisui Chemical Co Ltd, Petrochemicals, Deals By Type, 2011 to YTD 2017 32
Sekisui Chemical Co Ltd, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Apr 15, 2017: Sekisui Specialty Chemicals Announces Global Price Increase 34
Mar 29, 2017: Sekisui Chemical: Commercialize film type dye sensitized solar cell by room temperature process 35
Feb 15, 2017: Sekisui Specialty Chemicals Announces Global Price Increase 36
Dec 01, 2016: Sekisui Specialty Chemicals Announces Asia Price Increase 37
Oct 01, 2016: Sekisui Specialty Chemicals Announces Global Price Increase 38
Aug 15, 2016: Sekisui Europe Announces Methyl Acetate Price Increase 39
Jun 07, 2016: SEKISUI: The 3rd Factory Of High Performance Plastic Sheets In United States Starts Production 40
May 20, 2016: Sekisui’s High Purity Methyl Acetate Capacity Expansion 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Sekisui Chemical Co Ltd, Key Facts 6
Sekisui Chemical Co Ltd, Key Employees 7
Sekisui Chemical Co Ltd, Key Employee Biographies 8
Sekisui Chemical Co Ltd, Major Products and Services 9
Sekisui Chemical Co Ltd, History 10
Sekisui Chemical Co Ltd, Other Locations 14
Sekisui Chemical Co Ltd, Subsidiaries 14
Sekisui Chemical Co Ltd, Key Competitors 23
Sekisui Chemical Co Ltd, Ratios based on current share price 24
Sekisui Chemical Co Ltd, Annual Ratios 25
Sekisui Chemical Co Ltd, Annual Ratios (Cont...1) 26
Sekisui Chemical Co Ltd, Annual Ratios (Cont...2) 27
Sekisui Chemical Co Ltd, Interim Ratios 29
Sekisui Chemical Co Ltd, Petrochemicals, Deals By Year, 2011 to YTD 2017 31
Sekisui Chemical Co Ltd, Petrochemicals, Deals By Type, 2011 to YTD 2017 32
Sekisui Chemical Co Ltd, Recent Deals Summary 33
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

★海外企業調査レポート[Sekisui Chemical Co Ltd (4204):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carnegie Private Bank:企業の戦略・SWOT・財務情報
    Carnegie Private Bank - Strategy, SWOT and Corporate Finance Report Summary Carnegie Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Innovate Biopharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Innovate Biopharmaceuticals Inc (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company’s pipeline product includes INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 in phase …
  • Planmeca Oy:企業の戦略的SWOT分析
    Planmeca Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Xenon Pharmaceuticals Inc (XENE):企業の財務・戦略的SWOT分析
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that develops medicines to treat neurological disorders. The company is investigating XEN1101, a Kv7 potassium channel modulator against epilepsy; XEN496 for the treatment of seizures associated wi …
  • Orange SA (ORA):企業の財務・戦略的SWOT分析
    Orange SA (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Dassault Systemes SA (DSY):医療機器:M&Aディール及び事業提携情報
    Summary Dassault Systemes SA (Dassault) is a 3D experience company that offers software applications and services. Dassault offers consulting services in the areas of design, deployment, support, training, and engineering services. The company serves various industries including aerospace and defens …
  • SACI Falabella:企業の戦略・SWOT・財務情報
    SACI Falabella - Strategy, SWOT and Corporate Finance Report Summary SACI Falabella - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • nib Holdings Ltd:企業の戦略・SWOT・財務分析
    nib Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary nib Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Norwegian Cruise Line Holdings Ltd. (NCLH):企業の財務・戦略的SWOT分析
    Norwegian Cruise Line Holdings Ltd. (NCLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Grupo Nacional Provincial, S.A.B.:企業の戦略・SWOT・財務分析
    Grupo Nacional Provincial, S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Nacional Provincial, S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Strategic Energy Resources Ltd (SER):企業の財務・戦略的SWOT分析
    Summary Strategic Energy Resources Ltd (SER) is a mining company. It explores, develops, and produces mineral properties. The company product offerings include gold, copper and mineral sands. SER holds in Saxby gold project, Myall Creek project, Billa Kalina Copper-Gold Project and East Tennant copp …
  • Select Medical Holdings Corp (SEM):企業の財務・戦略的SWOT分析
    Summary Select Medical Holdings Corp (SMHC) is a healthcare service provider that offers outpatient rehabilitation services. The center provides long-term acute care services such as cardiac services, infectious disease treatment, medically complex treatment, neuro or post-trauma, pulmonary or venti …
  • AEON Co Ltd (8267):企業の戦略的SWOT分析
    AEON Co Ltd (8267) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • JSS Medical Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary JSS Medical Research Inc (JSS Medical Research) is a contract research organization that offers clinical research services. The organization provides clinical trial services in therapeutic areas such as oncology, infectious disease, cardiovascular disorders, psychiatry, neurology, respirator …
  • Aerovironment Inc
    Aerovironment Inc - Strategy, SWOT and Corporate Finance Report Summary Aerovironment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • UniQure NV (QURE):製薬・医療:M&Aディール及び事業提携情報
    Summary UniQure NV (UniQure) develops and markets gene therapy products. The company develops adeno-associated virus based gene therapies using its gene technology platform. UniQure offers clinical and preclinical programs for lipoprotein lipase deficiency, hemophilia A and B, Huntington’s disease, …
  • WAVE Life Sciences Ltd (WVE):製薬・医療:M&Aディール及び事業提携情報
    Summary WAVE Life Sciences Ltd (WAVE Life Sciences), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities such as exon-skipping and single-stranded RNAi, and ant …
  • Tuesday Morning Corporation (TUES):企業の財務・戦略的SWOT分析
    Tuesday Morning Corporation (TUES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Profectus BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Profectus BioSciences Inc (Profectus), formerly Maryland Biotherapeutics Inc is a clinical-stage vaccine development company that designs and develops vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company's products comprise genevax therapeutic vaccine …
  • Kayne Anderson MLP Investment Company:企業のM&A・事業提携・投資動向
    Kayne Anderson MLP Investment Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kayne Anderson MLP Investment Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆